NPPES file of Aug 9, 2026

Jonathan Redlinski, PHARMD

Pharmacotherapy Pharmacist · Wrangell, AK

Jonathan Redlinski, PHARMD is a pharmacotherapy pharmacist with a practice address in Wrangell, Alaska, and NPI 1114730090, issued on Jan 27, 2025. Check the license (Alaska 126105, as entered in NPPES) with the Alaska board that licenses this profession; the federal record below is the public data PlainDoctor holds for this provider.

Record from CMS NPPES, file of Aug 9, 2026 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1114730090
Name
Jonathan Redlinski
Credential
PHARMD
Primary taxonomy
Pharmacotherapy Pharmacist 1835P1200X
License number
126105 AK
Self-reported in NPPES; status is on the state search
Practice location
232 Wood Street, Wrangell, AK 99929
Phone
(907) 874-5005
Enumerated
Jan 27, 2025
Record last updated
Jan 27, 2025
Fax
(907) 600-5105
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 232 Wood Street

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Torehn Thompson, RDN, LDRegistered Dietitian1366325425

Verify Jonathan Redlinski in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersWhich Alaska board licenses this profession
    Search for license 126105
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Find the Alaska license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

1 pharmacotherapy pharmacist records list a practice address in Wrangell

They are 1 of the 94 NPPES records with a practice address in Wrangell, and 15 pharmacotherapy pharmacist records in Alaska. No Medicare prescribing, quality score, industry payment or hospital affiliation is published for this NPI.

Other pharmacotherapy pharmacist records in Alaska

  1. Mike Beiergrohslein, PHARM.D.Anchorage, AK1134167299
  2. Heidi Brainerd, RPH, MS, BCPSAnchorage, AK1568649507
  3. Amber Briggs, PHARM.D.Soldotna, AK1144225012
  4. Cindy Bueler, R.PH.Anchorage, AK1972720563
  5. Evan Deisen, PHARMDJuneau, AK1639002769
  6. Rose Lamesjerant, PHARMDFairbanks, AK1326852427
  7. Rebecca Reyes, PHARM.D.Kotzebue, AK1396827044
  8. Ballard SaulAnchorage, AK1710546726
  9. Judith Thompson, PHARMDAnchorage, AK1013047992
  10. Carrie Urena, PHARMD, BCPSKlawock, AK1801617824

Common questions

What is Jonathan Redlinski, PHARMD's NPI number?

Jonathan Redlinski, PHARMD's National Provider Identifier (NPI) is 1114730090, issued on Jan 27, 2025. An NPI identifies a provider in billing; it is not a license.

Where is Jonathan Redlinski, PHARMD located?

The NPPES record lists a practice address at 232 Wood Street, Wrangell, AK, 99929. Phone: (907) 874-5005. Providers update this record themselves, so call before visiting.

How can I verify Jonathan Redlinski, PHARMD's license?

NPPES lists Alaska license number 126105, as entered by the provider. Search the Alaska board that licenses this profession; the NPPES record confirms identity only.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.